Kode Mata Kuliah | FA3233 / 2 SKS |
---|
Penyelenggara | 107 - Pharmaceutical Science and Technology / SF |
---|
Kategori | Lecture |
---|
| Bahasa Indonesia | English |
---|
Nama Mata Kuliah | Biofarmasi | Biopharmacy |
---|
Bahan Kajian | - Pengantar Biofarmasi
- Sifat fisikokimia
- Absorpsi dan Transit Gastrointestinal
- Aborpsi per-kutan
- Aborpsi pulmonar
- Absorpsi estravaskular lain
- Uji Disolusi Terbanding
- Bioekivalen
| - Introduction to Biopharmacy
- Physicochemical properties
- Absorption and Gastrointestinal Transit
- Percutaneous Aborption
- Pulmonary aborption
- Other estravascular absorption
- Comparative Dissolution Test
- Bioequivalence
|
---|
Capaian Pembelajaran Mata Kuliah (CPMK) | - Mampu menjelaskan pengaruh sifat fisikokimia dan kondisi fisiologis tubuh terhadap proses biofarmasetik obat, serta proses biofarmasetik dari berbagai bentuk sediaan dan rute administrasi obat
- Mampu mengaplikasikan konsep biofarmasi untuk mengoptimalkan kinerja sediaan farmasi
- Mampu mendesain evaluasi biofarmasetik dari berbagai bentuk sediaan farmasi, serta mendesain, menganalisis dan mengintepretasikan bioekivalensi
| - Able to explain the influence of physicochemical properties and physiological conditions of the body on drug biopharmaceutics processes, as well as biopharmaceutics processes of various forms of preparations and drug administration routes
- Able to apply biopharmaceutics concepts to optimize the performance of pharmaceutical preparations
- Able to design biopharmaceutical evaluations of various forms of pharmaceutical preparations, as well as design, analyze and interpret bioequivalence
|
---|
Metode Pembelajaran | Kuliah, tugas mandiri, tugas kelompok | Lecture, self-directed task, group assignment |
---|
Modalitas Pembelajaran | Visual, auditorial, sinkronous, asinkronous | Visual, auditorial; synchronous and asynchronous |
---|
Jenis Nilai | ABCDE |
---|
Metode Penilaian | UTS, UAS, Tugas (mandiri & kelompok) | Mid exam, final exam, assignment (individual and group) |
---|
Catatan Tambahan | | |
---|